- 現金殖利率: 0.78%、總殖利率: 0.78%、5年平均現金配發率: 65.69%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 0.88 | 214.29 | 0.30 | 0 | 0.00 | 0 | 34.09 | 0 | 0.00 | 0 | 34.09 | 0 |
| 2022 (9) | 0.28 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2021 (8) | -1.50 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2020 (7) | -0.58 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2019 (6) | 0.65 | -5.8 | 0.45 | -10.0 | 0.00 | 0 | 69.23 | -4.46 | 0.00 | 0 | 69.23 | -4.46 |
| 2018 (5) | 0.69 | 72.5 | 0.50 | 66.67 | 0.00 | 0 | 72.46 | -3.38 | 0.00 | 0 | 72.46 | -3.38 |
| 2017 (4) | 0.40 | -61.17 | 0.30 | -62.5 | 0.00 | 0 | 75.00 | -3.44 | 0.00 | 0 | 75.00 | -3.44 |
| 2016 (3) | 1.03 | -17.6 | 0.80 | 0.0 | 0.00 | 0 | 77.67 | 21.36 | 0.00 | 0 | 77.67 | 21.36 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | 0.23 | -36.11 | -45.24 | 0.28 | -3.45 | 27.27 | 1.03 | 28.75 | 14.44 |
| 24Q2 (19) | 0.36 | -18.18 | -10.0 | 0.29 | 16.0 | 866.67 | 0.80 | 81.82 | 66.67 |
| 24Q1 (18) | 0.44 | 2300.0 | 450.0 | 0.25 | 47.06 | 108.33 | 0.44 | -50.0 | 450.0 |
| 23Q4 (17) | -0.02 | -104.76 | 83.33 | 0.17 | -22.73 | 88.89 | 0.88 | -2.22 | 214.29 |
| 23Q3 (16) | 0.42 | 5.0 | -10.64 | 0.22 | 633.33 | 650.0 | 0.90 | 87.5 | 130.77 |
| 23Q2 (15) | 0.40 | 400.0 | 1900.0 | 0.03 | -75.0 | 117.65 | 0.48 | 500.0 | 700.0 |
| 23Q1 (14) | 0.08 | 166.67 | 180.0 | 0.12 | 33.33 | 142.86 | 0.08 | -71.43 | 180.0 |
| 22Q4 (13) | -0.12 | -125.53 | 62.5 | 0.09 | 325.0 | 132.14 | 0.28 | -28.21 | 118.67 |
| 22Q3 (12) | 0.47 | 2250.0 | 313.64 | -0.04 | 76.47 | 87.5 | 0.39 | 587.5 | 133.05 |
| 22Q2 (11) | 0.02 | 120.0 | 103.7 | -0.17 | 39.29 | 65.31 | -0.08 | 20.0 | 91.67 |
| 22Q1 (10) | -0.10 | 68.75 | 76.74 | -0.28 | 0.0 | 39.13 | -0.10 | 93.33 | 76.74 |
| 21Q4 (9) | -0.32 | -45.45 | 8.57 | -0.28 | 12.5 | 22.22 | -1.50 | -27.12 | -158.62 |
| 21Q3 (8) | -0.22 | 59.26 | 35.29 | -0.32 | 34.69 | 15.79 | -1.18 | -22.92 | -413.04 |
| 21Q2 (7) | -0.54 | -25.58 | -800.0 | -0.49 | -6.52 | -308.33 | -0.96 | -123.26 | -972.73 |
| 21Q1 (6) | -0.43 | -22.86 | -352.94 | -0.46 | -27.78 | -560.0 | -0.43 | 25.86 | -352.94 |
| 20Q4 (5) | -0.35 | -2.94 | -3400.0 | -0.36 | 5.26 | -325.0 | -0.58 | -152.17 | -189.23 |
| 20Q3 (4) | -0.34 | -466.67 | 0.0 | -0.38 | -216.67 | 0.0 | -0.23 | -309.09 | 0.0 |
| 20Q2 (3) | -0.06 | -135.29 | 0.0 | -0.12 | -220.0 | 0.0 | 0.11 | -35.29 | 0.0 |
| 20Q1 (2) | 0.17 | 1800.0 | 0.0 | 0.10 | -37.5 | 0.0 | 0.17 | -73.85 | 0.0 |
| 19Q4 (1) | -0.01 | 0.0 | 0.0 | 0.16 | 0.0 | 0.0 | 0.65 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/11 | 0.64 | -24.1 | 3.24 | 7.71 | 24.34 | 2.22 | N/A | - | ||
| 2024/10 | 0.84 | 12.42 | 79.76 | 7.07 | 26.68 | 2.51 | N/A | 去年度因生產不及所致 | ||
| 2024/9 | 0.75 | -19.02 | 18.62 | 6.23 | 21.83 | 2.3 | 2.73 | - | ||
| 2024/8 | 0.92 | 45.67 | 34.99 | 5.49 | 22.28 | 2.23 | 2.81 | - | ||
| 2024/7 | 0.63 | -6.83 | 19.27 | 4.57 | 20.0 | 2.17 | 2.89 | - | ||
| 2024/6 | 0.68 | -20.79 | 20.05 | 3.93 | 20.12 | 2.05 | 3.12 | - | ||
| 2024/5 | 0.86 | 67.93 | 42.56 | 3.25 | 20.13 | 2.06 | 3.09 | - | ||
| 2024/4 | 0.51 | -26.64 | 4.0 | 2.4 | 13.73 | 1.8 | 3.54 | - | ||
| 2024/3 | 0.7 | 17.08 | 11.88 | 1.89 | 16.69 | 1.89 | 3.15 | - | ||
| 2024/2 | 0.59 | -0.29 | 9.5 | 1.19 | 19.7 | 1.83 | 3.25 | - | ||
| 2024/1 | 0.6 | -6.6 | 31.95 | 0.6 | 31.95 | 1.85 | 3.21 | - | ||
| 2023/12 | 0.64 | 3.46 | 128.67 | 6.84 | 52.11 | 1.72 | 3.17 | 去年度因疫情影響所致 | ||
| 2023/11 | 0.62 | 32.15 | 54.7 | 6.2 | 47.05 | 1.71 | 3.18 | 去年度因疫情影響所致 | ||
| 2023/10 | 0.47 | -25.81 | 21.55 | 5.58 | 46.25 | 1.78 | 3.06 | - | ||
| 2023/9 | 0.63 | -7.84 | 55.57 | 5.12 | 49.01 | 1.84 | 2.76 | 去年度因疫情影響所致 | ||
| 2023/8 | 0.68 | 28.71 | 43.05 | 4.49 | 48.13 | 1.78 | 2.86 | - | ||
| 2023/7 | 0.53 | -6.22 | 28.95 | 3.8 | 49.08 | 1.7 | 3.0 | - | ||
| 2023/6 | 0.57 | -5.94 | 43.32 | 3.27 | 52.95 | 1.66 | 2.65 | 去年度因疫情影響所致 | ||
| 2023/5 | 0.6 | 22.51 | 52.6 | 2.71 | 55.13 | 1.71 | 2.56 | 去年度因疫情影響所致 | ||
| 2023/4 | 0.49 | -21.08 | 29.99 | 2.11 | 55.87 | 1.66 | 2.65 | 去年度因疫情影響所致 | ||
| 2023/3 | 0.62 | 14.6 | 109.04 | 1.62 | 65.9 | 1.62 | 2.43 | 去年度因疫情影響所致 | ||
| 2023/2 | 0.54 | 20.14 | 70.91 | 0.99 | 46.93 | 1.27 | 3.08 | 去年度因疫情影響所致 | ||
| 2023/1 | 0.45 | 61.85 | 25.73 | 0.45 | 25.73 | 1.13 | 3.47 | - | ||
| 2022/12 | 0.28 | -29.99 | -21.43 | 4.5 | 27.88 | 1.06 | 3.47 | - | ||
| 2022/11 | 0.4 | 3.83 | 39.44 | 4.22 | 33.43 | 1.19 | 3.1 | - | ||
| 2022/10 | 0.38 | -5.04 | 19.91 | 3.82 | 32.83 | 1.27 | 2.91 | - | ||
| 2022/9 | 0.4 | -15.26 | 21.95 | 3.43 | 34.45 | 1.29 | 2.6 | - | ||
| 2022/8 | 0.48 | 16.02 | 88.33 | 3.03 | 36.32 | 1.28 | 2.62 | 因疫情影響 | ||
| 2022/7 | 0.41 | 4.22 | 22.63 | 2.55 | 29.62 | 1.2 | 2.8 | - | ||
| 2022/6 | 0.39 | 0.14 | 44.17 | 2.14 | 31.06 | 1.17 | 2.74 | - | ||
| 2022/5 | 0.39 | 4.36 | 55.53 | 1.75 | 28.42 | 1.07 | 2.98 | 疫情影響 | ||
| 2022/4 | 0.38 | 26.9 | 20.74 | 1.35 | 22.21 | 0.99 | 3.21 | - | ||
| 2022/3 | 0.3 | -6.29 | 5.42 | 0.97 | 22.78 | 0.97 | 3.46 | - | ||
| 2022/2 | 0.32 | -11.61 | 3.33 | 0.68 | 32.37 | 1.03 | 3.27 | - | ||
| 2022/1 | 0.36 | 1.12 | 76.12 | 0.36 | 76.12 | 1.0 | 3.37 | 疫情影響 | ||
| 2021/12 | 0.36 | 24.25 | 171.12 | 3.52 | -11.47 | 0.96 | 3.71 | 疫情影響 | ||
| 2021/11 | 0.29 | -10.71 | 27.2 | 3.16 | -17.7 | 0.94 | 3.81 | - | ||
| 2021/10 | 0.32 | -3.43 | 1.39 | 2.87 | -20.49 | 0.91 | 3.94 | - | ||
| 2021/9 | 0.33 | 30.86 | 55.6 | 2.55 | -22.59 | 0.92 | 4.07 | 因疫情影響 | ||
| 2021/8 | 0.25 | -24.44 | -22.23 | 2.22 | -27.99 | 0.86 | 4.35 | - | ||
| 2021/7 | 0.34 | 22.52 | 71.88 | 1.97 | -28.67 | 0.86 | 4.35 | 因疫情影響 | ||
| 2021/6 | 0.27 | 8.03 | 42.92 | 1.63 | -36.32 | 0.84 | 4.74 | - | ||
| 2021/5 | 0.25 | -18.97 | -3.65 | 1.36 | -42.71 | 0.85 | 4.69 | - | ||
| 2021/4 | 0.31 | 10.79 | -0.67 | 1.11 | -47.58 | 0.9 | 4.41 | 因疫情影響 | ||
| 2021/3 | 0.28 | -8.15 | -48.24 | 0.79 | -55.81 | 0.79 | 5.27 | 因疫情影響 | ||
| 2021/2 | 0.31 | 50.64 | -55.06 | 0.51 | -59.1 | 0.64 | 6.51 | 因疫情影響 | ||
| 2021/1 | 0.2 | 55.68 | -63.99 | 0.2 | -63.99 | 0.56 | 7.47 | 因疫情影響 | ||
| 2020/12 | 0.13 | -41.7 | -77.95 | 3.97 | -48.5 | 0.67 | 6.31 | 因疫情影響 | ||
| 2020/11 | 0.22 | -28.82 | -54.92 | 3.84 | -46.04 | 0.75 | 5.63 | 因疫情影響 | ||
| 2020/10 | 0.32 | 48.19 | -49.69 | 3.61 | -45.37 | 0.85 | 4.96 | - | ||
| 2020/9 | 0.21 | -34.59 | -68.03 | 3.3 | -44.92 | 0.73 | 5.9 | 因疫情影響 | ||
| 2020/8 | 0.33 | 66.98 | -53.1 | 3.09 | -42.03 | 0.71 | 6.08 | 因疫情影響 | ||
| 2020/7 | 0.2 | 1.88 | -64.1 | 2.76 | -40.36 | 0.65 | 6.67 | 國外客戶因疫情影響關廠中,故無法出貨 | ||
| 2020/6 | 0.19 | -27.17 | -69.77 | 2.57 | -37.2 | 0.77 | 5.85 | 國外客戶因疫情影響關廠中,故無法出貨 | ||
| 2020/5 | 0.26 | -16.46 | -65.71 | 2.37 | -31.22 | 1.12 | 4.01 | 國外客戶因疫情影響關廠中,故無法外銷出貨 | ||
| 2020/4 | 0.31 | -42.27 | -58.71 | 2.11 | -21.37 | 1.54 | 2.91 | 國外客戶因疫情影響關廠中,故無法外銷出貨 | ||
| 2020/3 | 0.55 | -20.24 | -10.33 | 1.8 | -6.55 | 1.8 | 2.32 | - | ||
| 2020/2 | 0.68 | 20.69 | 11.88 | 1.25 | -4.81 | 1.84 | 2.26 | - | ||
| 2020/1 | 0.57 | -4.66 | -19.34 | 0.57 | -19.34 | 0.0 | N/A | - | ||
| 2019/12 | 0.59 | 19.17 | 16.44 | 7.71 | -0.44 | 0.0 | N/A | - |
